Preclinical investigation of internal limiting membrane staining and peeling using intravitreal brilliant blue G

Retina

Volumn 26, Issue 6, 2006, Pages 623-630

  Enaida, Hiroshi ^a   Hisatomi, Toshio ^a   Goto, Yoshinobu ^a   Hata, Yasuaki ^a   Ueno, Akifumi ^a   Miura, Muneki ^a   Kubota, Toshiaki ^b   Ishibashi, Tatsuro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Brilliant blue G; Internal limiting membrane peeling; Preclinical investigation; Retinal damage; Retinal function; Vitrectomy

Indexed keywords

BRILLIANT BLUE; COLORING AGENT; COOMASSIE BRILLIANT BLUE; DIAGNOSTIC AGENT; FUCHSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL VACUOLE; CILIARY DISK; CONTROLLED STUDY; DRUG MEGADOSE; ELECTRON MICROSCOPY; ELECTRORETINOGRAPHY; ENUCLEATION; GAS; HISTOLOGY; INTERNAL LIMITING MEMBRANE; MALE; MICROSCOPY; NONHUMAN; OPHTHALMODYNAMOMETRY; RAT; RETINA; RETINA CELL; RETINA INJURY; RETINA SURGERY; STAINING; SURGICAL TECHNIQUE; TOXICITY TESTING; VITRECTOMY; VITREOUS BODY; ANIMAL; APOPTOSIS; BASEMENT MEMBRANE; BROWN NORWAY RAT; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG SCREENING; EPIRETINAL MEMBRANE; FLUORESCENCE ANGIOGRAPHY; INJECTION; MACACA; METHODOLOGY; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; RETINA DISEASE; ULTRASTRUCTURE;

ANIMALS; APOPTOSIS; BASEMENT MEMBRANE; COLORING AGENTS; DRUG EVALUATION, PRECLINICAL; ELECTRORETINOGRAPHY; EPIRETINAL MEMBRANE; FLUORESCEIN ANGIOGRAPHY; IN SITU NICK-END LABELING; INJECTIONS; MACACA FASCICULARIS; MALE; MICROSCOPY, ELECTRON; RATS; RATS, INBRED BN; RETINA; RETINAL DISEASES; ROSANILINE DYES; STAINING AND LABELING; VITRECTOMY; VITREOUS BODY;

EID: 33747374405     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200607000-00006     Document Type: Article

References (35)

1. Burk SE, Da Mata AP, Snyder ME, et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000;107:2010-2014.
2. Kadonosono K, Itoh N, Uchio E, et al. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
3. Feron EJ, Veckeneer M, Parys-Van Ginderdeuren R, et al. Trypan blue staining of epiretinal membranes in proliferative vitreoretinopathy. Arch Ophthalmol 2002;120:141-144.
4. Perrier M, Sebag M. Trypan blue-assisted peeling of the internal limiting membrane during macular hole surgery. Am J Ophthalmol 2003;135:903-905.
5. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 2001;131:387-388.
6. Kusaka S, Hayashi N, Ohji M, et al. Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalmol 2001;131:388-390.
7. Haritoglou C, Eibl K, Schaumberger M, et al. Functional outcome after trypan blue-assisted vitrectomy for macular pucker: a prospective, randomized, comparative trial. Am J Ophthalmol 2004;138:1-5.
8. Enaida H, Sakamoto T, Hisatomi T, et al. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 2002;240:209-213.
9. Sippy BD, Engelbrecht NE, Hubbard GB, et al. Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol 2001;132:433-435.
10. Stalmans P, Van Aken EH, Veckeneer M, et al. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2002;134:282-285.
11. Gandorfer A, Haritoglou C, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 2001;132:431-433.
12. Haritoglou C, Gandorfer A, Gass CA, et al. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002;134:836-841.
13. Uemura A, Kanda S, Sakamoto Y, Kita H. Visual field defects after uneventful vitrectomy for epiretinal membrane with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2003;136:252-257.
14. Veckeneer M, van Overdam K, Monzer J, et al. Ocular toxicity study of trypan blue injected into the vitreous cavity of rabbit eyes. Graefes Arch Clin Exp Ophthalmol 2001;239:698-704.
15. Haritoglou C, Gandorfer A, Schaumberger M, et al. Trypan blue in macular pucker surgery: an evaluation of histology and functional outcome. Retina 2004;24:582-590.
16. Yam HF, Kwok AK, Chan KP, et al. Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2003;44:370-377.
17. Kawaji T, Hirata A, Inomata Y, et al. Morphological damage in rabbit retina caused by subretinal injection of indocyanine green. Graefes Arch Clin Exp Ophthalmol 2004;242:158-164.
18. Rezai KA, Farrokh-Siar L, Ernest JT, van Seventer GA. Indocyanine green induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 2004;137:931-933.
19. Murata M, Shimizu S, Horiuchi S, Sato S. The effect of indocyanine green on cultured retinal glial cells. Retina 2005;25:75-80.
20. Rezai KA, Farrokh-Siar L, Gasyna EM, Ernest JT. Trypan blue induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 2004;138:492-495.
21. Kwok AK, Yeung CK, Lai TY, et al. Effects of trypan blue on cell viability and gene expression in human retinal pigment epithelial cells. Br J Ophthalmol 2004;88:1590-1594.
22. Hisatomi T, Enaida H, Matsumoto H, et al. The biocompatibility of brilliant blue G: preclinical study of brilliant blue G as an adjunct for capsular staining. Arch Ophthalmol (in press).
23. Thresher RJ, Ehrenberg M, Machemer R. Gas-mediated vitreous compression: an experimental alternative to mechanized vitrectomy. Graefes Arch Clin Exp Ophthalmol 1984;221:192-198.
24. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eyes. Arch Ophthalmol 1991;109:718-722.
25. Araiz JJ, Refojo MF, Arroyo MH, et al. Antiproliferative effect of retinoic acid in intravitreous silicone oil in an animal model of proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1993;34:522-530.
26. Bryan JS, Friedman SM, Mames RN, Margo CE. Experimental vitreous replacement with perfluorotri-n-propylamine. Arch Ophthalmol 1994;112:1098-1102.
27. Sakamoto T, Ueno H, Goto Y, et al. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Muller cells. Gene Ther 1998;5:1088-1097.
28. Hisatomi T, Sakamoto T, Murata T, et al. Relocalization of apoptosis-inducing factor in photoreceptor apoptosis induced by retinal detachment in vivo. Am J Pathol 2001;158:1271-1278.
29. Hisatomi T, Sakamoto T, Sonoda KH, et al. Clearance of apoptotic photoreceptors: elimination of apoptotic debris into the subretinal space and macrophage-mediated phagocytosis via phosphatidylserine receptor and integrin alphavbeta3. Am J Pathol 2003;162:1869-1879.
30. Goto Y, Yasuda T, Tobimatsu S, Kato M. 20-Hz flicker stimulus can isolate the cone function in rat retina. Ophthalmic Res 1998;30:368-373.
31. Goto Y, Tobimatsu S, Shigematsu J, et al. Properties of rat cone-mediated electroretinograms during light adaptation. Curr Eye Res 1999;19:248-253.
32. Sakamoto T, Miyazaki M, Hisatomi T, et al. Triamcinolone-assisted pars plana vitrectomy improves the surgical procedures and decreases the postoperative blood-ocular barrier breakdown. Graefes Arch Clin Exp Ophthalmol 2002;240:423-429.
33. Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy. Am J Ophthalmol 2003;135:243-246.
34. Enaida H, Hata Y, Ueno A, et al. Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases. Retina 2003;23:764-770.
35. Enaida H, Hata Y, Ueno A, et al. Visualization of the Cloquet canal during triamcinolone-assisted vitrectomy. Arch Ophthalmol 2004;122:1564-1565.